Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Metastasis Cancer Patients
Keywords:
peritoneal metastasis, cytoreductive surgery, hyperthermic intraperitoneal chemotherapyAbstract
Peritoneal metastasis is judged to be the end-stage of disease for cancer patients. Suitable treatments are palliative surgery, systemic chemotherapy, and palliative care, which aim to slow disease progression. However, due to the tumor burden, patients usually suffer from symptoms of gut obstruction, malnutrition, and the side effects of chemotherapy, which are the main causes of death. Nowadays, hyperthermic intraperitoneal chemotherapy (HIPEC) is one effective procedure to prolong survival for patients with peritoneal metastasis related to colon cancer, ovarian cancer, pseudomyxoma peritonei, mesothelioma, and gastric cancer.
References
Li Y, Zhou YF, Liang H, Wang HQ, Hao JH, Zhu ZG, et al. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol 2016;22:6906-16.
Benson III AB, Venook AP, Cederquist L, Chan E, Chen YJ, Cooper HS, et al. Clinical prectice guideline in oncology: colon cancer, version 1.2017. J Natl Compr Cancer Netw 2017;15:370-98.
Roviello F, Roviello G, Petrioli R, Marrelli D. Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results. Crit Rev Oncol Hematol 2015;95:297-305.
Van der Speeten K, Stuart OA, Sugarbaker PH. Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy. Surg Oncol Clin N Am 2012;21:577-97.
Braam HJ, Schellens JH, Boot H, van Sandick JW, Knibbe CA, Boerma D, et al. Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer. Crit Rev Oncol Hematol 2015;95:28296.
Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358-63.
Elias D, Bonnay M, Puizillou JM, Antoun S, Demirdjian S, El OA, et al. Heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol 2002;13:267-72.
Glehen O, Osinsky D, Cotte E, Kwiatkowski F, Freyer G, Isaac S, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003;10:863-9.
Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995;221:29-42.
Hall B, Padussis J, Foster JM. Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastasis. Surg Clin North Am 2017;97:671-82.
Determining the Peritoneal Cancer Index. Available from: http://www.hipec.com/knowledge-base/determining-the-peritoneal-cancer-index. Accessed August 31, 2018.
Hyperthermic intraperitoneal chemotherapy. Available from: http://en.wikipedia.org/wiki/hyperthermic_ intraperitoneal_chemotherapy. Accessed August 31, 2018.
Sugarbaker PH, Deraco M, Glehen O, Helm CW, Morris DL, Van der Speeten K. Cytoreductive Surgery and Perioperative Chemotherapy for Peritoneal Surface Malignancy, Textbook and Video Atlas.2nd Edition. Canada: Cine-med Inc; 2017.
Helm CW. Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer. Surg Oncol Clin N Am 2012;21:645-63.
Chua TC, Chong CH, Morris DL. Peritoneal mesothelioma: current status and future directions. Surg Oncol Clin N Am 2012;21:635-43.
Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012;30:2449-56.
Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996;82:359-74.
Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol 2012;30:263-7.
Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, et al. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 patients with Colorectal Cancer with Peritoneal Carcinomatosis. Ann Surg Oncol 2014;21:4195-201.
Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006;354:34-43.
Spiliotis J, Halkia E, Lianos E, Kalantzi N, Grivas A, Efstathiou E, et al. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol 2015;22:1570-5.
Votanopoulos KI, Shen P, Stewart JH 4th, Levine EA. Current status and future directions in appendiceal cancer with peritoneal dissemination. Surg Oncol Clin N Am 2012;21:599-609.
Feldman AL, Libutti SK, Pingpank JF, Bartlett DL, Beresnev TH, Mavroukakis SM, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003;21:4560-7.
Yonemura Y, de Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E, et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology 2001; 48:1776-82.
Zhu ZG, Tang R, Yan M, Chen J, Yang QM, Li S, et al. Clinical effect of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 2006;9:26-30.
Glockzin G, Piso P. Current status and future directions in gastric cancer with peritoneal dissemination. Surg Oncol Clin N Am 2012;21:625-33.
Downloads
Published
Issue
Section
License
บทความทีตีพิมพ์ในวารสารโรคมะเร็งนี้ถือว่าเป็นลิขสิทธิ์ของมูลนิธิสถาบันมะเร็งแห่งชาติ และผลงานวิชาการหรือวิจัยของคณะผู้เขียน ไม่ใช่ความคิดเห็นของบรรณาธิการหรือผู้จัดทํา
